📰 Bryan Crowe News
Bryan Crowe News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bryan Crowe. Real-time updates on events, politics, business and more.
May 6, 2024
TARRYTOWN, N.Y., May 06, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: RBC Capital Markets Global Healthcare Conference at 9:00 a.m. ET on
May 3, 2024
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
May 2, 2024
First quarter 2024 revenues decreased 1% to $3.15 billion versus first quarter 2023; excluding RonapreveTM, revenues increased 7%First quarter 2024 Dupixent® global net sales increased 24% to...
April 1, 2024
TARRYTOWN, N.Y., April 01, 2024 -- Regeneron Pharmaceuticals, Inc. today announced that it will report its first quarter 2024 financial and operating results on Thursday, May 2, 2024, before the...
February 6, 2024
TARRYTOWN, N.Y., Feb. 06, 2024 -- Regeneron Pharmaceuticals, Inc. will webcast management participation as follows: Oppenheimer 34th Annual Healthcare Life Sciences Conference at 1:20 p.m. ET on...
February 3, 2024
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2023 Earnings Call Transcript February 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $10.19 EPS, expectations were $10.43. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
February 2, 2024
Fourth quarter 2023 revenues increased 1% to $3.43 billion versus fourth quarter 2022; excluding RonapreveTM, revenues increased 14%Full year 2023 revenues increased 8% to $13.12 billion versus full...
January 5, 2024
TARRYTOWN, N.Y., Jan. 05, 2024 -- Regeneron Pharmaceuticals, Inc. today announced that it will report its fourth quarter and full year 2023 financial and operating results on Friday, February 2,...
December 18, 2023
TARRYTOWN, N.Y., Dec. 18, 2023 -- Regeneron Pharmaceuticals, Inc. will webcast its presentation at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. The presentation is...
December 18, 2023
18.12.2023 - TARRYTOWN, N.Y., Dec. 18, 2023 (GLOBE NEWSWIRE) - Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. The presentation is scheduled for 2:15 ...